Uniqueness of oral contraceptive progestins

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Gonane progestins are more potent and, except for levonorgestrel, less androgenic than the estrane progestins that preceded them. The current, informal method for classifying oral contraceptives (OCs) as old, first generation, or second generation on the basis of their date of introduction obscures the fact that each of the gonane progestins has unique biologic properties. Recommended, instead, is the classification of OCs according to their level of androgenicity. Under such a system, norgestimate, desogestrel, and monophasic norethindrone (0.4-0.5 mg) would fall into the low category. Triphasic levonorgestrel, norethindrone (1.0 mg), norethindrone acetate (1.0 mg), and ethynodiol diacetate (1.0 mg) would be classified as having medium androgenicity, while norgestrel (0.3 mg), norethindrone acetate (1.5-2.5 mg), and levonorgestrel (0.15 mg) would fall into the high androgenicity category.

Original languageEnglish (US)
Pages (from-to)23-27
Number of pages5
JournalContraception
Volume58
Issue number3 SUPPL.
StatePublished - Sep 1998

Fingerprint

Levonorgestrel
Gonanes
Progestins
Oral Contraceptives
Norethindrone
Estranes
Ethynodiol Diacetate
Norgestrel
Desogestrel
norethindrone acetate

ASJC Scopus subject areas

  • Medicine(all)
  • Obstetrics and Gynecology

Cite this

Uniqueness of oral contraceptive progestins. / Carr, Bruce R.

In: Contraception, Vol. 58, No. 3 SUPPL., 09.1998, p. 23-27.

Research output: Contribution to journalArticle

Carr, BR 1998, 'Uniqueness of oral contraceptive progestins', Contraception, vol. 58, no. 3 SUPPL., pp. 23-27.
Carr, Bruce R. / Uniqueness of oral contraceptive progestins. In: Contraception. 1998 ; Vol. 58, No. 3 SUPPL. pp. 23-27.
@article{02c20154bb424af99027a7425fe091dc,
title = "Uniqueness of oral contraceptive progestins",
abstract = "Gonane progestins are more potent and, except for levonorgestrel, less androgenic than the estrane progestins that preceded them. The current, informal method for classifying oral contraceptives (OCs) as old, first generation, or second generation on the basis of their date of introduction obscures the fact that each of the gonane progestins has unique biologic properties. Recommended, instead, is the classification of OCs according to their level of androgenicity. Under such a system, norgestimate, desogestrel, and monophasic norethindrone (0.4-0.5 mg) would fall into the low category. Triphasic levonorgestrel, norethindrone (1.0 mg), norethindrone acetate (1.0 mg), and ethynodiol diacetate (1.0 mg) would be classified as having medium androgenicity, while norgestrel (0.3 mg), norethindrone acetate (1.5-2.5 mg), and levonorgestrel (0.15 mg) would fall into the high androgenicity category.",
author = "Carr, {Bruce R.}",
year = "1998",
month = "9",
language = "English (US)",
volume = "58",
pages = "23--27",
journal = "Contraception",
issn = "0010-7824",
publisher = "Elsevier USA",
number = "3 SUPPL.",

}

TY - JOUR

T1 - Uniqueness of oral contraceptive progestins

AU - Carr, Bruce R.

PY - 1998/9

Y1 - 1998/9

N2 - Gonane progestins are more potent and, except for levonorgestrel, less androgenic than the estrane progestins that preceded them. The current, informal method for classifying oral contraceptives (OCs) as old, first generation, or second generation on the basis of their date of introduction obscures the fact that each of the gonane progestins has unique biologic properties. Recommended, instead, is the classification of OCs according to their level of androgenicity. Under such a system, norgestimate, desogestrel, and monophasic norethindrone (0.4-0.5 mg) would fall into the low category. Triphasic levonorgestrel, norethindrone (1.0 mg), norethindrone acetate (1.0 mg), and ethynodiol diacetate (1.0 mg) would be classified as having medium androgenicity, while norgestrel (0.3 mg), norethindrone acetate (1.5-2.5 mg), and levonorgestrel (0.15 mg) would fall into the high androgenicity category.

AB - Gonane progestins are more potent and, except for levonorgestrel, less androgenic than the estrane progestins that preceded them. The current, informal method for classifying oral contraceptives (OCs) as old, first generation, or second generation on the basis of their date of introduction obscures the fact that each of the gonane progestins has unique biologic properties. Recommended, instead, is the classification of OCs according to their level of androgenicity. Under such a system, norgestimate, desogestrel, and monophasic norethindrone (0.4-0.5 mg) would fall into the low category. Triphasic levonorgestrel, norethindrone (1.0 mg), norethindrone acetate (1.0 mg), and ethynodiol diacetate (1.0 mg) would be classified as having medium androgenicity, while norgestrel (0.3 mg), norethindrone acetate (1.5-2.5 mg), and levonorgestrel (0.15 mg) would fall into the high androgenicity category.

UR - http://www.scopus.com/inward/record.url?scp=0031738268&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031738268&partnerID=8YFLogxK

M3 - Article

VL - 58

SP - 23

EP - 27

JO - Contraception

JF - Contraception

SN - 0010-7824

IS - 3 SUPPL.

ER -